Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cecchini

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
Cancer Research Communications|June 30, 2023
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal CancerMichael Cecchini, Janie Y Zhang, Wei Wei, et al.
Cancer|March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trialDeborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
JAMA Network Open|November 26, 2025
Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal CancerMelissa Taylor, Sarah J Westvold, Jessica B Long, et al.
Cancer Research Communications|April 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study FindingsJames J Harding, Ralf Hofheinz, Elena Élez, et al.
Clinical and Translational Radiation Oncology|January 4, 2021
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisJoseph A Miccio, Wesley J Talcott, Timil Patel, et al.
Journal for Immunotherapy of Cancer|June 8, 2023
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshopGuy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, et al.
JAMA Network Open|July 12, 2023
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the USMadhav Kc, Jane Fan, Terry Hyslop, et al.
Journal of Geriatric Oncology|November 30, 2025
Personalized risk assessment of frailty in long-term cancer survivorsRebecca Forman, Sarah J Westvold, Jessica B Long, et al.
The New England Journal of Medicine|June 3, 2026
Targeting of Wnt-β-Catenin Pathway in Recurrent AmeloblastomaSamuel J Klempner, Moh'd Khushman, Kyriakos P Papadopoulos, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Communications Medicine|July 20, 2022
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancerChen Li, Ana Ferro, Shivani K Mhatre, et al.
Cancer Research Communications|June 30, 2023
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal CancerMichael Cecchini, Janie Y Zhang, Wei Wei, et al.
Cancer|March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trialDeborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
JAMA Network Open|November 26, 2025
Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal CancerMelissa Taylor, Sarah J Westvold, Jessica B Long, et al.
Cancer Research Communications|April 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study FindingsJames J Harding, Ralf Hofheinz, Elena Élez, et al.
Clinical and Translational Radiation Oncology|January 4, 2021
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisJoseph A Miccio, Wesley J Talcott, Timil Patel, et al.
Journal for Immunotherapy of Cancer|June 8, 2023
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshopGuy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, et al.
JAMA Network Open|July 12, 2023
Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the USMadhav Kc, Jane Fan, Terry Hyslop, et al.
Journal of Geriatric Oncology|November 30, 2025
Personalized risk assessment of frailty in long-term cancer survivorsRebecca Forman, Sarah J Westvold, Jessica B Long, et al.
The New England Journal of Medicine|June 3, 2026
Targeting of Wnt-β-Catenin Pathway in Recurrent AmeloblastomaSamuel J Klempner, Moh'd Khushman, Kyriakos P Papadopoulos, et al.
Pageof 7